Dynamic India is expanding its commercial manufacturing, services, and products sales into global marketspaces. The benefits these have for Indian trade positions and reputations are complex. As sales expand so do requirements benefiting global and domestic populations.
Recent experiences with global markets and the Indian pharmaceutical products enterprises see these lessons in a global marketplace (in excess of USD$25B with a CAGR of ~7%).
Dynamic India’s growth in pharmaceuticals, bioproducts, and healthcare products has been a key market driver of export, and exchange. The rapid growth of this sector applying Indian domain knowledge, know-how, and selling models creates a positive feedback loop. The feedback sees Indian enterprises forced into addressing regulatory compliance, manufacturing excellence, and target market consumerism. These factors in turn benefit domestic Indian markets by making the simplest delivery, production, and packaging, upgraded for scale, into global products and services.
Indian enterprises in global marketspaces have grown with experience in vaccine production, consumer child medications, and global licensing. Each of these experiences provides specific lessons for many participants in Dynamic India’s growth and maturity.
To get more specifics on what India is doing in the pharma and healthcare marketplace read - Part 2 of Pharma export growth. It will appear on our website – www.ekalore.com/india-business.
Comments